Neuro-stellar

Neurostellar operates at the intersection of consumer health technology, neuroscience, wearables, and sports performance. Its differentiation is the emphasis on mental fitness: Orbit is described as measuring brain and body signals to assess focus, cognitive load, and recovery, with interpretation supported by performance coaching and an in-house neuroscience orientation. The company also targets athletes and executives, giving it a narrower performance-oriented audience than broad consumer wellness platforms. Its technology claims include EEG, ECG, and PPG/HRV measurement, artifact removal and feature extraction, and machine-learning or deep-learning models for cognitive metrics. Neurostellar’s Chennai base and backing from IIT Mandi Catalyst, Swapnil Jain, and Tarun Mehta provide early ecosystem and investor validation, but its $150,000 disclosed funding total and 11-50 employee range indicate an early-stage position.

Neurostellar appears to be progressing from research-led development toward a more complete consumer mental-fitness product. Founded in 2021, it recorded an initial seed round on Jan 1, 2023 involving IIT Mandi Catalyst, followed by a $150,000 seed round on May 12, 2025 from Swapnil Jain and Tarun Mehta. The 2025 financing is the main visible inflection point: it increased disclosed funding to $150,000 and was associated with public attention around the company’s deep-technology focus. Orbit provides a tangible product direction, combining EEG and PPG sensing with cognitive-performance reporting, personalized guidance, and longer-term trend analysis. Hiring for mechanical design, machine learning and signal processing, and creative media suggests the company is building across device engineering, algorithm development, and market communication rather than concentrating exclusively on research. The 11-50 employee range indicates a small operating base capable of specialized development but still limited in scale. There is no disclosed valuation, revenue, customer count, large commercial launch, or subsequent financing after May 2025. Consequently, the trajectory supports early productization and team expansion, but not yet evidence of broad commercial acceleration.